Products tagged with 'Retatrutide'
Retatrutide ZPHC (AQ pen) — 30 mg Premixed Pen
Retatrutide Retatrutide — 30 mg (6 vials × 5 mg) GLP-1, GIP, and Glucagon receptor triple agonist 6 lyophilised vials × 5 mg (total 30 mg) Research focus: potent multi-receptor activation for enhanced weight loss, improved metabolic control, and appetite suppression. Once-weekly injection.
RETATRUTIDE 20 ZPHC
Retatrutide Retatrutide GLP-1, GIP, and Glucagon receptor triple agonist Research focus: potent multi-receptor activation for enhanced weight loss, improved metabolic control, and appetite suppression. Once-weekly injection.
RETATRUTIDE 40 ZPHC
Retatrutide Retatrutide GLP-1, GIP, and Glucagon receptor triple agonist Research focus: potent multi-receptor activation for enhanced weight loss, improved metabolic control, and appetite suppression. Once-weekly injection.
RETATRUTIDE 60 ZPHC
Retatrutide Retatrutide GLP-1, GIP, and Glucagon receptor triple agonist Research focus: potent multi-receptor activation for enhanced weight loss, improved metabolic control, and appetite suppression. Once-weekly injection.